Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

CV Sciences, Inc. (CVSI)

OQB · Drug Manufacturers - Specialty & Generic

$0.020.00 (0.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$4.1M
P/E (TTM)
EPS
$-0.01
Div Yield
52W Range
$0.02–$0.10
Beta
0.44

Company overview

CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

42 employeeswww.cvsciences.com

Peers in Healthcare

CV Sciences, Inc. has no peer companies in this window.

Recent press releases

CV Sciences, Inc. has not issued a press release in this window.

SEC filings

All filings →

CV Sciences, Inc. has not filed an SEC document in this window.

CV Sciences, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2024-09-30 · prior 2024-06-30

People at CV Sciences, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$1.6M
NI -$109.0K
06/25
$1.5M
NI -$261.0K
09/25
$3.3M
NI -$382.0K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline
CV Sciences, Inc. (CVSI) Stock Quote, Press... | Cayman Journal | Cayman Journal